Literature DB >> 15315155

Construction, expression and identification of a recombinant BCG vaccine encoding human Mycobacterium tuberculosis heat shock protein 65.

Wuxing Dai1, Liang Liang, Hong Gao, Hailang Huang, Zhihao Chen, Jizhong Cheng, Yongmu Huangfu.   

Abstract

Heat shock protein 65 (HSP65) is one of the most important protective immunogens against the tuberculosis infection. The signal sequence of antigen 85B and the whole HSP65 DNA sequence of human Mycobacterium tuberculosis (M. tuberculosis) were amplified from BCG genome and plasmid pCMV-MTHSP65 respectively by polymerase chain reactions (PCR). These two sequences were cloned into the plasmid pBCG-2100 under the control of the promoter of heat shock protein 70 (HSP70) from human M. tuberculosis, yielding the prokaryotic shuttle expression plasmid pBCG-SP-HSP65. Results of restriction endonuclease analysis, PCR detection and DNA sequencing analysis showed that the two cloned DNA sequences were consistent with those previously reported, and the direction of their inserting into the recombinant was correct and the reading frame had been maintained. The recombinants were electroporated into BCG to construct the recombinant BCG vaccine and induced by heating. The induced expression detected by SDS-PAGE showed that the content of 65 kD protein expressed in recombinant BCG was 35.69% in total bacterial protein and 74.09% in the cell lysate supernatants, suggesting that the recombinant HSP65 gene could express in BCG with high efficiency and the expressed proteins were mainly soluble. Western-blot showed that the secretive recombinant proteins could specifically combine with antibody against M. tuberculosis HSP65, indicating that the recombinant proteins possess the biological activity of HSP65.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315155     DOI: 10.1007/BF02885404

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  Driving a stake into resurgent TB.

Authors:  M Enserink
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

2.  A simple method of DNA extraction from Mycobacterium tuberculosis.

Authors:  M Jaber; A Rattan; A Verma; J Tyagi; R Kumar
Journal:  Tuber Lung Dis       Date:  1995-12

3.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.

Authors:  I M Orme; A D Roberts; J P Griffin; J S Abrams
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

4.  Protection against tuberculosis by a plasmid DNA vaccine.

Authors:  D B Lowrie; C L Silva; M J Colston; S Ragno; R E Tascon
Journal:  Vaccine       Date:  1997-06       Impact factor: 3.641

5.  Therapy of tuberculosis in mice by DNA vaccination.

Authors:  D B Lowrie; R E Tascon; V L Bonato; V M Lima; L H Faccioli; E Stavropoulos; M J Colston; R G Hewinson; K Moelling; C L Silva
Journal:  Nature       Date:  1999-07-15       Impact factor: 49.962

6.  The 65-kilodalton antigen of Mycobacterium tuberculosis.

Authors:  T M Shinnick
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

7.  Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein.

Authors:  S H Kaufmann; U Väth; J E Thole; J D Van Embden; F Emmrich
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

Review 8.  A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

Authors:  E M Agger; P Andersen
Journal:  Vaccine       Date:  2002-11-22       Impact factor: 3.641

9.  Expression of foreign gene in mycobacterium regulated by human Mycobacterium tuberculosis heat shock protein 70 promoter.

Authors:  J Cheng; Y Huangfu; Z Feng; J Liang; H Xiao
Journal:  J Tongji Med Univ       Date:  1997
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.